Since TNF-α and proinflammatory interleukins contribute to COPD progression [111], lowering TNF-α and IL-1, IL-8, and IL-10 may improve both systemic inflammation in COPD and cardiovascular risk. This evidence concerns the gene TNF and chronic obstructive pulmonary disease.